Tag

Grk2

All articles tagged with #grk2

science3 hours ago•5 min saved

GRK2: A Fresh Target for Alzheimer’s Therapy Shows Promise in Mice

Scientists identify the enzyme GRK2, and its inactive form, as a new target in Alzheimer's disease. In mouse models and some human brain tissue, inactive GRK2 accumulates with mitochondria, boosting amyloid-beta production and harming mitochondrial function. The compound dubbed Compound 10 prevents GRK2 from clumping, restoring mitochondrial health, reducing amyloid-beta, and slowing dementia progression in mice, marking a potential new therapeutic avenue that still needs validation in humans.

via ScienceAlert|

#alzheimers #amyloid-beta #compound-10

science1 day ago•5 min saved

GRK2 Breakthrough Could Redirect Alzheimer’s Treatment Path

ETH Zurich researchers identify inactive GRK2 aggregates that disrupt mitochondrial energy and drive amyloid beta buildup in Alzheimer’s, forming a damaging feedback loop. They developed Compound 10, which blocks GRK2 aggregation, preserves mitochondrial function, reduces amyloid beta, and slows nerve-cell loss in mice, suggesting a new upstream therapeutic approach that could complement existing treatments; a patent has been filed and industry partnerships are being pursued.

via SciTechDaily|

#alzheimers #compound-10 #grk2

science3 days ago•8 min saved

GRK2-targeting Compound 10 slows Alzheimer’s progression in mouse models

ETH Zurich researchers identified that inactivated GRK2 aggregates in dementia brains damage mitochondrial function and accelerate amyloid-beta production, creating a self-perpetuating cycle. They developed Compound 10 to prevent GRK2 aggregation, which improved mitochondrial energy, reduced amyloid-beta, and extended survival in Alzheimer’s mouse models, with additional systemic anti-aging benefits observed. The basic research is complete and a patent has been filed; industry partnership is sought to advance toward clinical development.

via Neuroscience News|

#alzheimers-disease #amyloid-beta #compound-10